BKD · NYSE · STOCK
Brookdale Senior Living (BKD) Stock Analysis
$10.12
52W $8.02 – $17.09
46/100
$2.42B
-17.5
0.53
Is BKD Bullish or Bearish?
Mixed.
Innellis AI committee rates Brookdale Senior Living Inc. (BKD) Watch with a composite score of 46/100
, based on 6 analysts with 50% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +13.85 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -6.15 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.25 across 8 articles, 14d). Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- News sentiment is positive (+0.25 across 8 articles, 14d) — News
Bear Case
- Price-to-book of 4.7x prices in significant intangible value — Value
- ROE of only -128.1% -- cheap may mean cheap for a reason — Value
- Debt-to-equity of 20.55 adds balance-sheet risk to the value case — Value
- Revenue declining -4.4% YoY -- this is not a growth story right now — Growth
- Price structure making lower highs and lower lows — Technical
- RSI at 22 is in oversold territory (could mean either capitulation or a bounce setup) — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
46/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 97%
of 192 Healthcare peers
Value Analyst
bearish
32
/ 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− Price-to-book of 4.7x prices in significant intangible value
Growth Analyst
neutral
50
/ 100 · Moderate confidence
Moderate growth -- present but not remarkable
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− Revenue declining -4.4% YoY -- this is not a growth story right now
Technical Analyst
bearish
31
/ 100 · High confidence
Price action is deteriorating -- trend and/or momentum are working against this name
− Price structure making lower highs and lower lows
Risk Analyst
bearish
33
/ 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 20.55) amplifies downside in a stress scenario
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
66
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.25 across 8 articles, 14d)
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 49.1 to 46.1.
- Committee agreement increased notably from 33% to 50%.
- New bearish signals: 5 appeared.
- Bullish support removed: 2 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
- Analyst(s) changed stance: Technical Analyst.
Analyst-level changes:
- News Analyst: +1 bullish signal(s).
- Risk Analyst: +1 bearish signal(s).
- Technical Analyst: stance neutral->bearish; score 46->31 (-15); +4 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
22.5
Oversold
MACD Histogram
-0.010
Bearish Momentum
Trend Direction
Downtrend
Weekly: Uptrend
Market Structure
Mixed
Support
$10.11
Resistance
$11.33
Bollinger %B
-0.07
Below Lower Band
Price vs Moving Averages
EMA 9
$10.75
Below
EMA 21
$11.13
Below
EMA 50
$11.92
Below
EMA 200
$12.38
Below
Fundamental Analysis
Valuation
100
Growth
88
Profitability
25
Financial Health
64
Cash Flow
70
Valuation
P/E Ratio
-17.5×
P/B Ratio
-83.52×
PEG Ratio
-0.43
Dividend Yield
0.00%
52W High
$17.09
52W Low
$8.02
Quality & Growth
ROE
—
ROA
-441.3%
Gross Margin
1443.2%
Operating Margin
375.1%
Revenue Growth YoY
—
Debt / Equity
-44.49
AI Fundamental Assessment
P/E ratio of -17.5 (inexpensive relative to a 15-40x range); Price-to-book of -83.5x; PEG ratio of -0.4 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 587.0%; Return on assets of -4.4%; Net margin of -4.6%; Gross margin of 14.4%; Current ratio of 1.14 (tight short-term liquidity); Debt-to-equity of -44.49; Free cash flow per share is positive (0.10); Most recent quarter beat estimates by 278.3%; EPS growth accelerating (+82.4% -> +433.3% QoQ); Average YoY EPS growth of 155.6%; Analyst estimates rising over recent quarters
Get the Full BKD Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →